Accendra Health Inc (ACH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,100,642 | -362,686 | -41,301 | 1,915,120 | 1,577,711 |
| Depreciation Amortization | 214,524 | 488,393 | 210,371 | 1,562,036 | 1,320,946 |
| Income taxes - deferred | -17,887 | -8,042 | -6,004 | N/A | N/A |
| Accounts receivable | 122,363 | -3,677 | -8,991 | -192,650 | -200,718 |
| Accounts payable and accrued liabilities | 6,478 | 66,894 | 5,245 | 683,342 | 204,365 |
| Other Working Capital | 65,943 | 24,072 | 137,377 | -238,070 | 352,462 |
| Other Operating Activity | 607,431 | -43,459 | 444,013 | 292,894 | 1,175,196 |
| Operating Cash Flow | $-101,790 | $161,495 | $740,710 | $4,022,673 | $4,429,963 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 2,016,508 |
| PPE Investments | -112,988 | -100,360 | -100,801 | -633,364 | -161,335 |
| Net Acquisitions | 324,260 | N/A | N/A | 13,701 | 11,289 |
| Purchase Of Investment | N/A | N/A | N/A | -2,222,641 | -53,510 |
| Sale Of Investment | N/A | N/A | N/A | 2,185,246 | 7,908 |
| Purchase Sale Intangibles | -10,369 | -12,379 | -6,156 | -42,882 | -10,236 |
| Other Investing Activity | -66,849 | -16,173 | -36,453 | 161,453 | -1,937,657 |
| Investing Cash Flow | $144,423 | $-116,533 | $-137,254 | $-495,605 | $-116,797 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,914,784 | 635,800 | N/A | 4,583,113 | 8,534,587 |
| Debt Issued | N/A | 1,465,800 | 476,000 | 297,222 | N/A |
| Debt Repayment | N/A | -1,709,997 | -892,693 | -368,762 | -845,220 |
| Common Stock Issued | N/A | N/A | N/A | 58,674 | N/A |
| Common Stock Repurchased | -10,179 | 0 | 0 | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | -364,356 | -72,301 |
| Other Financing Activity | -2,716,527 | -659,206 | -637 | -8,125,996 | -10,516,710 |
| Financing Cash Flow | $188,078 | $-267,603 | $-417,330 | $-3,920,105 | $-2,899,644 |
| Exchange Rate Effect | 1,896 | -901 | 613 | -22,629 | 11,599 |
| Beginning Cash Position | 49,382 | 272,924 | 86,185 | 2,853,856 | 1,376,443 |
| End Cash Position | 281,989 | 49,382 | 272,924 | 2,438,190 | 2,801,564 |
| Net Cash Flow | $232,607 | $-223,542 | $186,739 | $-415,666 | $1,425,121 |
| Free Cash Flow | |||||
| Operating Cash Flow | -101,790 | 161,495 | 740,710 | 4,022,673 | 4,429,963 |
| Capital Expenditure | -190,956 | -170,286 | -172,375 | -640,305 | -320,019 |
| Free Cash Flow | -292,746 | -8,791 | 568,335 | 3,382,368 | 4,109,944 |